According to Fortune Business Insights, the global sequencing reagents market size was valued at USD 9.96 billion in 2025. The market is projected to grow from USD 11.35 billion in 2026 to USD 28.32 billion by 2034, exhibiting a CAGR of 12.11% during the forecast period. Market expansion is primarily driven by increasing adoption of next-generation sequencing (NGS), rising demand for personalized medicine, growing genomic research activities, and advancements in molecular diagnostics.
Sequencing reagents are specialized chemical substances, enzymes, kits, buffers, and nucleotides used in DNA and RNA sequencing processes to analyze genetic material. These reagents play a critical role in sequencing workflows by enabling sample preparation, amplification, labeling, sequencing reactions, and data generation. Sequencing reagents are extensively used in genomics research, precision medicine, cancer diagnostics, infectious disease testing, and drug discovery applications.
Get a Free Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/sequencing-reagents-market-115363
Market Segmentation
By Sequencing Technology
- Next-Generation Sequencing (NGS)
- Sanger Sequencing
- Third-Generation Sequencing
By Product Type
- Library Preparation Reagents
- Sequencing Kits
- Control Reagents
- Amplification Reagents
- Purification Reagents
By Application
- Oncology
- Reproductive Health
- Clinical Diagnostics
- Drug Discovery
- Agriculture & Animal Research
- Forensics
- Infectious Disease Testing
Regional Analysis
- North America dominates the sequencing reagents market due to advanced healthcare infrastructure, high genomics research funding, and widespread adoption of next-generation sequencing technologies. The region benefits from the presence of major biotechnology and sequencing companies, along with strong government support for precision medicine initiatives. The U.S. remains the leading contributor owing to increasing investments in cancer genomics and molecular diagnostics.
- Asia Pacific is expected to be the fastest-growing region due to rising healthcare investments, expanding biotechnology industries, and increasing adoption of genomic testing in countries such as China, India, Japan, and South Korea. Government initiatives supporting precision medicine and genomics research are significantly driving regional market growth.
- Europe represents a substantial market owing to increasing research funding, growing adoption of personalized medicine, and expansion of genomic testing programs. Countries such as Germany, the UK, and France are actively investing in genomics infrastructure and molecular diagnostics technologies.
- Meanwhile, Latin America and the Middle East & Africa are gradually witnessing increased adoption of sequencing technologies due to improving healthcare infrastructure and growing awareness regarding genetic testing.
Competitive Analysis
The sequencing reagents market is highly competitive and innovation-driven, with leading biotechnology companies focusing heavily on research and development to improve sequencing accuracy, efficiency, and throughput. Companies are introducing advanced reagent kits designed for high-speed sequencing and low-input sample analysis.
Strategic collaborations between sequencing technology providers, pharmaceutical companies, and research institutions are increasingly common. Mergers, acquisitions, and partnerships are helping companies expand their product portfolios and strengthen their market presence globally.
Competition is intensifying due to the growing demand for precision medicine and large-scale genomics projects. Companies are also investing in automation and AI-driven sequencing workflows to improve operational efficiency and reduce sequencing costs.
Key Players
- Illumina, Inc.(S.)
- Thermo Fisher Scientific Inc. (U.S.)
- QIAGEN (Netherlands)
- Agilent (U.S.)
- Hoffmann-La Roche Ltd (Switzerland)
- Oxford Nanopore Technologies plc (U.K.)
- PacBio (U.S.)
- Twist Bioscience (U.S.)
Report Coverage
- Market size and forecast analysis
- Detailed segmentation by technology, product type, and application
- Regional market insights and country-level analysis
- Competitive landscape and company profiling
- Market drivers, restraints, and opportunities
- Technological advancements in sequencing technologies
- Regulatory and genomics industry analysis
Key Takeaways
- The sequencing reagents market is growing rapidly due to expanding genomics applications
- Next-generation sequencing remains the dominant technology segment
- North America leads the market, while Asia Pacific is the fastest-growing region
- Precision medicine and oncology diagnostics are major growth drivers
- Technological innovation and genomics research investments are shaping future market expansion
Key Industry Development
- November 2025: QIAGEN acquired Parse Biosciences, a leading provider of scalable, instrument-free solutions for single-cell research.
- November 2025: Volta Labs and New England Biolabs announced a co-development partnership to expand the portfolio of NEBNext reagents on the Callisto Sample Preparation Platform.
Get Your Customization Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/sequencing-reagents-market-115363
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights Pvt. Ltd.
9th Floor, Icon Tower,
Baner - Mahalunge Road, Baner,
Pune-411045, Maharashtra, India.
Phone:
US: +18339092966
UK: +448085020280
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com